Literature DB >> 16170751

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients.

Raymund R Razonable1, Robert A Brown, Atul Humar, Emma Covington, Emma Alecock, Carlos V Paya.   

Abstract

In this study of 263 heart, kidney, liver, and pancreas transplant patients, BK virus (BKV) and JC virus (JCV) DNAemia were observed most commonly in kidney and/or pancreas transplant patients (26%), although they were also observed, to a lesser extent, in heart (7%) and liver (4%) transplant patients. The majority of episodes of polyomavirus DNAemia were subclinical, although, in some cases, BKV DNAemia was associated with kidney rejection, and JCV DNAemia was accompanied by nonspecific symptoms. Hence, BKV and JCV DNAemia are not uncommon during the first year after kidney, heart, liver, and pancreas transplantation, and they could be associated with certain clinical syndromes in transplant patients.

Entities:  

Mesh:

Year:  2005        PMID: 16170751     DOI: 10.1086/466532

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?

Authors:  Supha Kijpittayarit; Raymund R Razonable
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

2.  Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.

Authors:  Steven Gabardi; Sushrut S Waikar; Spencer Martin; Keri Roberts; Jie Chen; Lea Borgi; Hussein Sheashaa; Christine Dyer; Sayeed K Malek; Stefan G Tullius; Nidyanandh Vadivel; Monica Grafals; Reza Abdi; Nader Najafian; Edgar Milford; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

3.  Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation.

Authors:  Lora D Thomas; Aaron P Milstone; Regis A Vilchez; Preeti Zanwar; Janet S Butel; J Stephen Dummer
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

Review 4.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

Review 5.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

6.  Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Jennifer A Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Brock C Christensen; Anne G Hoen; Ann E Perry; Michael Pawlita; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-11       Impact factor: 4.254

7.  Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.

Authors:  R Ettenger; H Chin; K Kesler; N Bridges; P Grimm; E F Reed; M Sarwal; R Sibley; E Tsai; B Warshaw; A D Kirk
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

8.  Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.

Authors:  S Gabardi; S Ramasamy; M Kim; R Klasek; D Carter; M R Mackenzie; A Chandraker; C S Tan
Journal:  Transpl Infect Dis       Date:  2015-06-26       Impact factor: 2.228

Review 9.  Different behaviour of BK-virus infection in liver transplant recipients.

Authors:  Ilaria Umbro; Francesca Tinti; Paolo Muiesan; Anna Paola Mitterhofer
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.

Authors:  P Randhawa; D Bohl; D Brennan; K Ruppert; B Ramaswami; G Storch; J March; R Shapiro; R Viscidi
Journal:  Clin Vaccine Immunol       Date:  2008-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.